Abstract:Background: The common cold is a frequent illness, which, although benign and self limiting, results in many consultations to primary care and considerable loss of school or work days. Current symptomatic treatments have limited benefit. Corticosteroids are an effective treatment in other upper respiratory tract infections and their anti-inflammatory effects may also be beneficial in the common cold. This updated review has included one additional study. Objectives: To compare corticosteroids versus usual care for the common cold on measures of symptom resolution and improvement in children and adults. Search methods: We searched Cochrane Central Register of Controlled Trials (CENTRAL 2015, Issue 4), which includes the Acute Respiratory Infections (ARI) Group's Specialised Register, the Database of Reviews of Effects (DARE) (2015, Issue 2), NHS Health Economics Database (2015, Issue 2), MEDLINE (1948 to May week 3, 2015) and EMBASE (January 2010 to May 2015). Selection criteria: Randomised, double-blind, controlled trials comparing corticosteroids to placebo or to standard clinical management. Data collection and analysis: Two review authors independently extracted data and assessed trial quality. We were unable to perform meta-analysis and instead present a narrative description of the available evidence. Main results: We included three trials (353 participants). Two trials compared intranasal corticosteroids to placebo and one trial compared intranasal corticosteroids to usual care; no trials studied oral corticosteroids. In the two placebo-controlled trials, no benefit of intranasal corticosteroids was demonstrated for duration or severity of symptoms. The risk of bias overall was low or unclear in these two trials. In a trial of 54 participants, the mean number of symptomatic days was 10.3 in the placebo group, compared to 10.7 in those using intranasal corticosteroids (P value = 0.72). A second trial of 199 participants reported no significant differences in the duration of symptoms. The single-blind trial in children aged two to 14 years, who were also receiving oral antibiotics, had inadequate reporting of outcome measures regarding symptom resolution. The overall risk of bias was high for this trial. Mean symptom severity scores were significantly lower in the group receiving intranasal steroids in addition to oral amoxicillin. One placebo-controlled trial reported the presence of rhinovirus in nasal aspirates and found no differences. Only one of the three trials reported on adverse events; no differences were found. Two trials reported secondary bacterial infections (one case of sinusitis, one case of acute otitis media; both in the corticosteroid groups). A lack of comparable outcome measures meant that we were unable to combine the data. Authors' conclusions: Current evidence does not support the use of intranasal corticosteroids for symptomatic relief from the common cold. However, there were only three trials, one of which was very poor quality, and there was limited statistical power overall. Further large, randomised, double-blind, placebo-controlled trials in adults and children are required to answer this question.

Multicenter Clinical Trial of Zinc Gluconate Nasal Spray and Cold Spray in the Treatment of Common Cold

Varenicline Solution Nasal Spray for Dry Eye Disease in Chinese Patients: a Randomized Phase 3 Trial

A Randomized Controlled Multicenter Clinical Trial on the Treatment of Common Cold with Fu-fang-an-fen-jia-ma Fluid

A Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Lvpuweima Sustained-Release Tablet in the Treatment of Common Cold

The efficacy and safety of Baoji Tablets for treating common cold with summer-heat and dampness syndrome: study protocol for a randomized controlled trial

Efficacy and safety of Lian-Ju-Gan-Mao capsules for treating the common cold with wind-heat syndrome: study protocol for a randomized controlled trial

Supporting Respiratory Epithelia and Lowering Inflammation to Effectively Treat Common Cold Symptoms: A Randomized Controlled Trial

Efficacy and Safety of Loratadine Paracetamol and Pseudoephedrine Sustained Release Tablets in the Treatment of Common Cold and Influenza

Peceleganan Spray for the Treatment of Skin Wound Infections: A Randomized Clinical Trial

Clinical study of the combination therapy with intranasal antihistamine and nasal corticosteroids in the treatment of nasal obstruction of persistent non-allergic rhinitis

Early intervention with a glycerol throat spray containing cold-adapted cod trypsin after self-diagnosis of common cold: A randomised trial.

New Strategy for Cough Treatment-Comparison Effect and Safety of Cofetol Cough Syrup with Dextromethorphan Hydrobromide, Chorpheniramine Mateate and Pseudoe Phedrine Hydiochloride Solution in the Treatment of Acute Cough

Chinese patent medicines for the treatment of the common cold: a systematic review of randomized clinical trials

Clinical Trial of Yupingfeng Granules in Recuperation of Qi-deficient Constitution with Recurrent Common Cold

Effect and Safety of Pseudoephedrine-Dextromethorphan Drops

Efficacy and Safety of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray in Treating Allergic Rhinitis: a Randomized Controlled Trial

A Multi-Center Observation of the Therapeutic Efficacy of Bencycloquidium Bromide in the Treatment of Seasonal Allergic Rhinitis with Predominant Symptoms of Rhinorrhea

Corticosteroids for the common cold

A real-world study of quality of life following treatment with xylometazoline hydrochloride in individuals with common cold

Analysis of the efficacy of azelastine nasal spray combined with mussel mucin in the treatment of allergic rhinitis and the influence of peripheral blood CCL26 and CCR3 levels.

Multi-center, randomized, blinded, parallel control clinical study of cefazedone injection and cefazolin injection in the treatment of acute bacterial respiratory infections